Journal of Medical Ethics 43 (12):803-809 (2017)

Luke Gelinas
Albany Medical College
It is not uncommon for multiple clinical trials at the same institution to recruit concurrently from the same patient population. When the relevant pool of patients is limited, as it often is, trials essentially compete for participants. There is evidence that such a competition is a predictor of low study accrual, with increased competition tied to increased recruitment shortfalls. But there is no consensus on what steps, if any, institutions should take to approach this issue. In this article, we argue that an institutional policy that prioritises some trials for recruitment ahead of others is ethically permissible and indeed prima facie preferable to alternative means of addressing recruitment competition. We motivate this view by appeal to the ethical importance of minimising the number of studies that begin but do not complete, thereby exposing their participants to unnecessary risks and burdens in the process. We then argue that a policy of prioritisation can be fair to relevant stakeholders, including participants, investigators and funders. Finally, by way of encouraging and helping to frame future debate, we propose some questions that would need to be addressed when identifying substantive ethical criteria for prioritising between studies.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1136/medethics-2016-103680
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 69,226
Through your library

References found in this work BETA

Non-Completion and Informed Consent.Alan Wertheimer - 2014 - Journal of Medical Ethics 40 (2):127-130.

Add more references

Citations of this work BETA

View all 12 citations / Add more citations

Similar books and articles

Priority, Prediction and the Ethical Research Enterprise.Spencer Phillips Hey - 2017 - Journal of Medical Ethics 43 (12):812-813.
What Makes Placebo-Controlled Trials Unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.


Added to PP index

Total views
11 ( #849,411 of 2,499,746 )

Recent downloads (6 months)
1 ( #418,066 of 2,499,746 )

How can I increase my downloads?


My notes